Globus Medical, Inc. (GMED)
NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous Close | 65.31 |
| Open | 64.87 |
| Bid | 48.00 x 1000 |
| Ask | 85.00 x 900 |
| Day's Range | 64.73 - 66.95 |
| 52 Week Range | 52.60 - 84.23 |
| Volume | |
| Avg. Volume | 657,074 |
| Market Cap | 6.631B |
| Beta (5Y Monthly) | 1.13 |
| PE Ratio (TTM) | 43.58 |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- Zacks
Globus Medical (GMED) Q2 Earnings Beat, Gross Margin Dips
Globus Medical's (GMED) Musculoskeletal Solutions products generate solid revenues on growth in spine and trauma implant portfolios.
- Motley Fool
Globus Medical (GMED) Q2 2022 Earnings Call Transcript
Joining today's call from Globus Medical will be Dan Scavilla, president and chief executive officer; and Keith Pfeil, senior vice president and chief financial officer. This review is being made available via webcast, accessible through the Investor Relations section of the Globus Medical website at www.globusmedical.com.
- Zacks
Globus Medical (GMED) Q2 Earnings and Revenues Top Estimates
Globus Medical (GMED) delivered earnings and revenue surprises of 3.70% and 2%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
© 2022 Yahoo. All rights reserved.
